Cognetivity to deploy ICA in UK residential dementia care practice

Published 15 September 2021

Cognetivity Neurosciences announced an agreement to deploy its integrated cognitive assessment (ICA) in UK dementia and senior care provider Loveday & Co.’s practice to monitor the cognitive health of its members. Financial terms of the deal were not disclosed.

CEO Sina Habibi said it is “exciting…to see ourselves branching out from more traditional assessments in the hospital clinic and into the residential and home care environments,” adding that “this is going to be a more and more important area as time goes on.”

According to Cognetivity, using the ICA will allow Loveday’s team “to identify when certain interventions may be needed and ensure members receive an appropriate, best-in-class care plan at the earliest possible stage.” Cognetivity also highlighted clinical trial data showing that the ICA can support the entire patient journey, from screening to longer-term monitoring.